Plasma Dabigatran Activity One Week After Discontinuation Despite Normal Renal Function - 23/07/13
Doi : 10.1016/j.amjmed.2013.02.023
Jecko Thachil, MD ⁎ 
, Gill Pike, MD, Lynne Keighley-Jones, FIBMS, Michael J. Nash, MD
, Gill Pike, MD, Lynne Keighley-Jones, FIBMS, Michael J. Nash, MD Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom
∗Requests for reprints should be addressed to Jecko Thachil, MD, Department of Haematology, Manchester Royal Infirmary, Oxford Road, Manchester, UK M13 9WL.
El texto completo de este artículo está disponible en PDF.
| Funding: None. |
|
| Conflict of Interest: MJN has received speaker fees from Bayer. JT has received speaker fees from Bayer and Boehringer Ingelheim. |
|
| Authorship: All authors had access to the data and played a role in writing this manuscript. |
© 2013
Elsevier Inc. Reservados todos los derechos.
Vol 126 - N° 8
P. e5-e6 - août 2013 Regresar al número
Artículo precedente
- Eagle's Syndrome
- Christoph Becker, Jens Pfeiffer
- Thyrotoxicosis and Neck Pain: Getting the Right Test at the Right Time
- Shahid Aziz, Ali Rizvi
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?